Literature DB >> 9512134

Different constitution of hepatitis C virus population in peripheral blood mononuclear cells and plasma in patients with type C chronic liver disease.

A Okumura1, K Yoshioka, T Aiyama, M Takayanagi, K Iwata, T Ishikawa, S Kakumu.   

Abstract

We searched for the presence of the plus or minus strand of hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells (PBMCs) from three patients with chronic HCV infection using the strand-specific reverse transcription and polymerase chain reaction (RT-PCR) method. To examine whether the HCV population of PBMCs differs from that of plasma, a sequence of the hypervariable region (HVR) in the E2/NS1 region was analyzed. All three patients had both plus and minus strands of HCV RNA in their PBMCs. Sequence study revealed that the HCV population in PBMCs was homogeneous in all patients, while that in plasma was composed of two main clones. One of these had the same sequence as the clones seen in PBMCs, except for one patient. Our results suggest that PBMCs represent one of the extrahepatic replication sites of HCV and that tissue tropism is expressed by some of the HCV population.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512134     DOI: 10.1023/a:1018822926124

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C.

Authors:  T L Fong; M Shindo; S M Feinstone; J H Hoofnagle; A M Di Bisceglie
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

2.  Infection of peripheral mononuclear blood cells by hepatitis C virus.

Authors:  A L Zignego; D Macchia; M Monti; V Thiers; M Mazzetti; M Foschi; E Maggi; S Romagnani; P Gentilini; C Bréchot
Journal:  J Hepatol       Date:  1992-07       Impact factor: 25.083

3.  Replication of hepatitis C virus in peripheral blood mononuclear cells. Effect of alpha-interferon therapy.

Authors:  C Qian; J Camps; M D Maluenda; M P Civeira; J Prieto
Journal:  J Hepatol       Date:  1992-11       Impact factor: 25.083

4.  Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells.

Authors:  J T Wang; J C Sheu; J T Lin; T H Wang; D S Chen
Journal:  J Infect Dis       Date:  1992-11       Impact factor: 5.226

5.  Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity.

Authors:  P Simmonds; F McOmish; P L Yap; S W Chan; C K Lin; G Dusheiko; A A Saeed; E C Holmes
Journal:  J Gen Virol       Date:  1993-04       Impact factor: 3.891

6.  A single nucleotide substitution in the internal ribosome entry site of foot-and-mouth disease virus leads to enhanced cap-independent translation in vivo.

Authors:  E Martínez-Salas; J C Sáiz; M Dávila; G J Belsham; E Domingo
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

7.  Presence of viral replicative intermediates in the liver and serum of patients infected with hepatitis C virus.

Authors:  A H Sherker; J S Twu; G R Reyes; W S Robinson
Journal:  J Med Virol       Date:  1993-02       Impact factor: 2.327

8.  Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients.

Authors:  A L Zignego; M De Carli; M Monti; G Careccia; G La Villa; C Giannini; M M D'Elios; G Del Prete; P Gentilini
Journal:  J Med Virol       Date:  1995-09       Impact factor: 2.327

9.  Hepatic and extrahepatic hepatitis C virus replication in relation to response to interferon therapy.

Authors:  M G Saleh; C J Tibbs; J Koskinas; L M Pereira; A B Bomford; B C Portmann; I G McFarlane; R Williams
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

10.  Comparison of the hypervariable region of hepatitis C virus genomes in plasma and liver.

Authors:  N Sakamoto; N Enomoto; M Kurosaki; Y Asahina; S Maekawa; K Koizumi; I Sakuma; T Murakami; F Marumo; C Sato
Journal:  J Med Virol       Date:  1995-05       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.